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Abstract 
Purpose: Mediterranean spotted fever (MSF) is the most prevalent zoonosis in Portugal. To characterize it’s evolution 
between 1989 and 2012, the authors reviewed the cases diagnosed at their unit during this period.
Methods: Review of clinical records of patients with MSF diagnosis, between 1989 and 2012.
Results: Data from 250 patients was included, 54% male. Mean age at diagnosis was 58 years (11–92). Mean annual 
incidence was 10 cases, with clear summer predominance. Most patients, 78% lived in rural areas, 34% had contact 
with dogs and 10% noticed the tick bite. Most common symptoms were: fever (98%), myo‑arthralgia (64%) and head‑
ache (48%). Maculopapular rash was noticed in 87%, affecting palms in 77% and soles in 69%. Inoculation eschar was 
found in 60%, mostly located on the trunk. Treatment included doxycycline in 86% and chloramphenicol in 12%, with 
a mean duration of 8 days. Most frequent blood test abnormalities were C‑reactive protein, lactatedehydrogenase, 
aspartate aminotransferase and alaninetransaminase elevations and thrombocytopenia. First serologic evaluation was 
positive in 37% (78/212), having seroconversion been documented in 85% (72/85). Most frequent complication was 
acute renal injury. ICU admission occurred in 5%. Average length of hospital stay was 11.2 days (1–106), with a mortal‑
ity of 3.6%.
Conclusions: In our series, there was clear summer predominance of MSF, which had rural origin in 78%. Most 
common symptoms were fever, myo‑arthralgia and headache. Maculopapular rash was noticed in 87% of cases and 
inoculation eschar in 60%. Most cases had favourable outcome, having 5% been admitted to ICU. Mortality was 3.6%.
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Background
Mediterranean spotted fever (MSF) is a zoonosis 
endemic in the Mediterranean basin. Conor and Bruch 
first described it in Tunisia in 1910 as a disease that 
caused high fever and spots. It was soon reported in 
other regions around the Mediterranean (Walker and 
Raoult 2010; Rovery et al. 2008; Rovery and Raoult 2008). 
In Portugal, Delfim Pinheiro made the description of the 
first cases in 1923 and in 1930, Ricardo Jorge’s work con-
tributed to the divulgation of the disease, naming it “febre 
escaro-nodular” (fever with eschar and nodules), name 
by which it is still known nowadays (Louro et  al. 2006; 
Sousa et al. 2003).
MSF is an emerging/reemerging disease in some coun-
tries in which it’s incidence has varied in a cyclic man-
ner (Rovery et al. 2008; Rovery and Raoult 2008; Oliveira 
and Côrte-Real 1999). Though its incidence in Portugal 
has decreased throughout the last decade, MSF is still the 
most prevalent zoonosis, with 140 cases notified in 2010 
(1024 cases in 1996) (Santos 2014). This result is probably 
biased by sub-notification. Although of mandatory noti-
fication in Portugal, it is estimated that only 14% of MSF 
cases are notified (Sousa et al. 2003).
The causative agent is Rickettsia conorii, an obligate 
intracellular and extremely fastidious Gram-negative 
bacterium (Oliveira and Côrte-Real 1999; Galvão et  al. 
2005). In Portugal, there are two strains of the Rickettsia 
conorii complex, the Malish and the Israeli tick typhus 
strain (Sousa et  al. 2003, 2008). The main vector of the 
disease is Rhipicephalus sanguineus, the brown dog tick 
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(Rovery et al. 2008; Rovery and Raoult 2008; Oliveira and 
Côrte-Real 1999; Figueira-Coelho et al. 2010; Duque et al. 
2012). The tick itself may acts as a reservoir for Rickettsia, 
as these bacteria can be maintained in ticks through tran-
stadial and transovarial transmission (Rovery et al. 2008; 
Sousa et  al. 2003; Duque et  al. 2012; Sociedade Portu-
guesa de Pediatria 2005; Parola et al. 2013; Brouqui et al. 
2004). Other reservoirs are thought to be dogs, rabbits 
and some small rodents (Rovery et al. 2008; Rovery and 
Raoult 2008; Sociedade Portuguesa de Pediatria 2005), 
but there is no consensus in this point. Humans are an 
accidental host of Rickettsia and play no role in maintain-
ing this bacterium in nature (Rovery and Raoult 2008; 
Galvão et al. 2005; Parola et al. 2013).
Although in some countries men are more affected than 
women (Rovery and Raoult 2008), gender distribution in 
Portugal is homogeneous (Sousa et al. 2003). Although it 
can affect individuals of all ages, in our country, the high-
est incidence rate is observed in children (1–4 years old). 
However, it is in the elderly patient and in people with 
comorbidities (diabetes mellitus, immunodepression, car-
diac pathology, chronic alcoholism and glucose-6-phos-
phate dehydrogenase deficiency) that the disease has 
higher complication and mortality rates (Sousa et al. 2003; 
Oliveira and Côrte-Real 1999; Parola et al. 2013).
The disease incidence has a seasonal variation, related 
with the tick activity, being more prevalent in hotter 
months, especially May through September. Yet still, 
cases have been reported throughout the whole year 
(Rovery and Raoult 2008; Oliveira and Côrte-Real 1999).
In Portugal, cases have been described in all districts, 
being more frequent in those of Bragança, Beja and 
Coimbra (Sousa et al. 2003).
After an asymptomatic incubation period (one  week), 
the onset of disease is usually abrupt (Rovery and Raoult 
2008). The classic clinical triad is composed of high 
fever (>39°C), maculopapular non-pruriginous rash with 
palmo-plantar involvement and an inoculation eschar at 
the site of the tick bite (Walker and Raoult 2010; Rovery 
and Raoult 2008; Sousa et  al. 2003; Oliveira and Côrte-
Real 1999). Flu-like symptoms are usually also present 
(Walker and Raoult 2010; Oliveira and Côrte-Real 1999; 
Parola et al. 2013). Faccini-Martínez et al. (2014) suggest 
MSF inclusion in the group of exanthematic rickettsioses 
syndrome with a probability of inoculation eschar and 
maculopapular/purpuric rash.
The pathogenic basis of the disease is a systemic vas-
culitis (La Scola and Raoult 1997), being the eschar the 
gateway of Rickettsia into the host organism and probably 
the first reaction of the organism to control the infection 
(Parola et al. 2013). It can be difficult to identify (Rovery 
et  al. 2008) and may even be absent in 14–40% of cases 
(Rovery and Raoult 2008), as it is common in infection 
by Rickettsia conorii subsp. israelensis (Sousa et al. 2003, 
2008; Parola et al. 2013; Bacellar et al. 1999). The descrip-
tion of cases with multiple eschars may be linked to the 
increasing aggressiveness of Rhipicephalus sanguineus, 
eventually related with climatic changes (Rovery and 
Raoult 2008; Parola et  al. 2013), but may also be related 
with other Rickettsiosis, such as lymphangitis associated 
rickettsioses (LAR), caused by Rickettsia sibirica (Fournier 
et al. 2005; Sousa et al. 2006; Pereira et al. 2011).
The diagnosis is based on clinical, epidemiological and 
laboratorial criteria (Oliveira and Côrte-Real 1999; Socie-
dade Portuguesa de Pediatria 2005). In Portugal, it is rec-
ommended that the suspected cases have a laboratorial 
confirmation (Sousa et al. 2003; Oliveira and Côrte-Real 
1999).
Complete blood count abnormalities are non-specific. 
Leukocytosis, leukopenia or normal white blood cell 
count may be present. Thrombocytopenia is frequent. 
Inflammatory markers (sedimentation rate or C-reac-
tive protein) and liver function tests are usually elevated 
(Oliveira and Côrte-Real 1999; Brouqui et al. 2004; Raoult 
et al. 1986).
Direct identification of Rickettsia by cellular culture, 
immune-histological techniques or PCR DNA amplifica-
tion test from skin or eschar biopsies is the most specific 
method of diagnosis (Walker and Raoult 2010; Sousa et al. 
2003). Recently, PCR from eschar swabs has been described 
as being equally useful in identification of Rickettsia (Parola 
et  al. 2013). The use of PCR allowed for the discovery of 
new species of Rickettsia, some of which could have been 
the cause of previously described atypical MSF cases, chal-
lenging classic taxonomy (Walker and Raoult 2010; Rov-
ery and Raoult 2008; Bacellar et al. 1999; Sousa et al. 2006, 
2013; Pereira et al. 2011; Raoult et al. 1997).
As direct identification of Rickettsia is expensive, and 
usually restricted to reference laboratories, serological 
tests are still the most widely available, easy to perform 
and most frequently used diagnostic method (Oliveira 
and Côrte-Real 1999; Parola et  al. 2013). Weil–Felix 
reaction is obsolete and not used anymore (Sousa et  al. 
2003; Oliveira and Côrte-Real 1999; Galvão et al. 2005), 
being immunofluorescence considered the gold standard 
by the WHO. The diagnosis is confirmed by serocon-
version or by a fourfold rise in titers between acute and 
convalescence serum samples (Oliveira and Côrte-Real 
1999; Sociedade Portuguesa de Pediatria 2005; Brouqui 
et al. 2004; La Scola and Raoult 1997). Notwithstanding 
this fact, the selection of antigens used in this method is 
limited and cross-reacts with different Rickettsia, mak-
ing it difficult to identify the definitive etiological agent 
(Brouqui et al. 2004; Pereira et al. 2011).
Keeping in mind that early and appropriate antibiotic 
prescription is crucial for a favourable outcome (Rovery 
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and Raoult 2008; Amaro et  al. 2003), clinical evaluation 
is still the fastest and most precious diagnostic weapon 
(Galvão et  al. 2005). A diagnostic scoring system has 
been developed to help in MSF diagnosis, based in epi-
demiologic, clinical and laboratory data (Brouqui et  al. 
2004; Cascio et al. 2002).
The treatment of MSF is based on antibiotics with good 
intracellular activity, being doxycycline, 100 mg 2id, the 
preferred (Rovery and Raoult 2008; Parola et  al. 2013; 
Faccini-Martínez et  al. 2014), even in pregnant women 
(severe cases) and children less than 8 years-old (Faccini-
Martínez et al. 2014), as the risk for dental staining is neg-
ligible when a single and short course of therapy is used 
(Rovery and Raoult 2008). Alternatives are macrolides, 
particularly interesting in pregnant women (Parola et al. 
2013; Faccini-Martínez et  al. 2014; Cascio et  al. 2002; 
Colomba et al. 2006) and chloramphenicol (Oliveira and 
Côrte-Real 1999; Faccini-Martínez et  al. 2014). Useful-
ness of fluoroquinolones has been questioned by recent 
studies (Parola et  al. 2013; Faccini-Martínez et  al. 2014; 
Botelho-Nevers et  al. 2011). A response-guided therapy 
is advised, keeping antibiotic therapy until 24–48 h after 
fever defervescence (Rovery and Raoult 2008; Sociedade 
Portuguesa de Pediatria 2005).
Clinical improvement usually occurs within 48  h of 
treatment initiation and patients usually recover within 
10 days with no sequelae. Although reinfection can occur 
in some patients, MSF is always an acute disease (Rovery 
and Raoult 2008).
Although usually benign, life-threatening cases may 
also occur, with sepsis, shock and multiple organ failure 
(Rovery and Raoult 2008; Oliveira and Côrte-Real 1999; 
Sousa et  al. 2008; Figueira-Coelho et  al. 2010; Duque 
et al. 2012; Parola et al. 2013; Amaro et al. 2003; Colomba 
et al. 2014).
As the vector and reservoirs for Rickettsia conorii move 
freely in nature, it is impossible to eradicate it (Sousa 
et  al. 2003; Sociedade Portuguesa de Pediatria 2005). 
Therefore, it is important to take measures to prevent 
infection, such as: avoiding tick infested areas, use of pro-
tective clothing and repellent, thorough search for ticks 
after possible environmental exposure or deworming 
of domestic reservoir animals (Oliveira and Côrte-Real 
1999; Sociedade Portuguesa de Pediatria 2005; Garcia-
Alvarez et al. 2013).
In order to better characterize it’s evolution between 
1989 and 2012, we reviewed the cases followed-up in the 
authors unit during this period.
Methods
The authors made a retrospective review of the files of 
the patients followed-up for MSF (as defined by the clini-
cal team that cared for the patient), between 1st January 
1989 and 31st December 2012. MSF diagnostic was based 
on clinical, epidemiological and laboratorial aspects. 
Serologic confirmation was considered when one of the 
following criteria was met: IgG >128 in acute phase test, 
seroconversion or fourfold titer rise between acute and 
convalescent test. In the cases in which this did not hap-
pen, clinical evaluation was considered the most impor-
tant diagnostic criteria.
Informed consent was obtained from the patients and 
their data was kept anonymous.
Results
Epidemiology
Data from 252 patients was collected, 250 were included 
(see atypical presentation in "Results"), 54% (n  =  134) 
male, with a male to female ratio of 1:0.87. Mean age at 
diagnosis was 58 years (11–92). Age distribution is shown 
in Additional file 1: Figure S1.
The mean annual incidence was 10 cases, varying from 
1 case in 1997 to 21 in 2004. Since then it was apparent 
a slight decrease in the number of cases diagnosed each 
year (Additional file 2: Figure S2). Clear summer pre-
dominance was observed (Additional file 3: Figure S3), 
with 78% of the cases occurring between July and Sep-
tember (n = 196). Despite this fact, there have been cases 
diagnosed in the months of February, November and 
December.
The most frequent comorbidities presented by the 
patients are shown in Additional file 4: Table S1.
The majority of patients (78%, n =  194) lived in rural 
areas. Contact with dogs was referred by 34% (n =  85) 
and only 10% (n = 26) noticed a tick bite.
Clinical presentation
At admission, patients reported in average 5.6  days 
(1–30) of evolution of symptoms.
The clinical manifestations are described in Additional 
file 5: Table S2. The most common symptoms were: fever 
(98%, n =  245), myalgia and arthralgia (64%, n =  159), 
headache (48%, n = 119) and asthenia (27%, n = 68).
On physical examination, maculopapular rash was 
noticed in 87% of patients (n = 218), affecting the palms 
in 77% (n = 168) and the soles in 69% (n = 150). The inoc-
ulation eschar (tache noire) was found in 60% (n = 151), 
being located on the trunk in 58% (87/151), lower limbs 
in 28% (42/151) and upper limbs in 11% of cases (16/151) 
(Additional file 6: Table S3). Multiple eschars were found 
in just 2% (3/151). Enlarged lymph nodes in the drainage 
area were present in 13% (19/151) of those with inocula-
tion eschar.
The characteristic rash was absent in 13% (n = 32) of 
patients. Of these, 34% (11/32) had fever and an inocula-
tion eschar.
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The classic triad of fever, maculopapular rash and inoc-
ulation eschar was present in 49% (123/250) of patients.
In patients with available data (n = 54), rash followed 
fever in 3.2 days (0–11).
Atypical presentations
The two cases excluded were considered probable cases 
of atypical rickettsioses and not atypical presentations 
of MSF. One of the cases was a patient who presented 
with flu-like symptoms, two eschars and lymphangitis 
from one of them to the draining node. The other was a 
38 year-old woman, who sought medical care after hav-
ing noticed an eschar in the head. Painful cervical lymph 
node enlargement was noticed, but she presented no 
other complaints. Both cases were treated with doxycy-
cline with complete recovery.
Throughout the period of the study, the eschar was 
detected in the head in only 3% (4/151) of cases. Another 
case, a 58  year-old male, also presented an inoculation 
eschar on the head, but presented the classical clinical 
triad of MSF in the month of June 2012. Culture and PCR 
DNA amplification of Rickettsia were not attempted in 
the last two cases.
One of the cases diagnosed in December, was a 33-year-
old male veterinarian, who noticed a tick-bite on his leg. 
He presented with fever, myalgia, headache and an inoc-
ulation eschar on the right leg, with enlarged inguinal 
lymph nodes. No rash was noticed. Serologic test was 
positive both in the acute and convalescence phase, with 
a eightfold increase in titter (from 160 to 1280). He was 
given doxycycline and had a favourable outcome.
Laboratory results
In what regards complete blood cell count evaluation, 
10% (25/240) presented leukopenia (<4 G/L) and 19% 
(46/240) leucocytosis (>10 G/L). Thrombocytopenia 
(<150 G/L) was detected in 60% (151/250) and thrombo-
cytosis (>400 G/L) in only 2% (5/250).
The most frequent biochemistry panel abnormalities 
were C-reactive protein (98%, 229/234), lactate dehydro-
genase (LDH—86%, 206/240), aspartate aminotransferase 
(AST—74%, 184/249), alanine transaminase (ALT—54%, 
135/250) and gamma-glutamyl transpeptidase (gamma-
GT—47%, 118/250) elevations.
The acute phase serology (immunofluorescence assay—
taken at admission) was done in 85% (n = 212) of cases 
and was positive in 37% (78/212). Seroconversion was 
documented in 85% (72/85). In 62% (131/212) of patients, 
paired serologies were obtained. Convalescent phase 
serologies were done 6–8  weeks after the acute phase 
ones. In 14% (n =  35) of patients, no serology test was 
done. The results of serologic evaluations are described 
in Additional file 7: Table S4. In this table, although the 
titers values begin in 1/80, only titers above 1/128 were 
considered diagnostic. In the authors hospital only IgG 
titers were made available. Serologic tests for other path-
ogens were also done, but their results were not collected.
Identification of Rickettsia subspecies was tried in 21 
cases, by culture and PCR amplification (tests done in the 
National Institute of Health). In two cases it was identi-
fied the Malish strain of Rickettsia conorii and in two 
other, the Israeli spotted fever strain (all four had sero-
logic seroconversion documented). No identification was 
possible in the 17 remaining cases.
Treatment and outcome
The treatment included doxycycline in 86% (n = 215) and 
chloramphenicol in 12% (n = 30), with a mean duration 
of 8 days. Azithromycin was only used once, in a 14-year-
old boy, with resolution of disease.
The most frequent complication was acute renal injury, 
observed in 16% (n = 40) of cases and respiratory failure, 
in 15% (n =  37). Multiple organ failure justified admis-
sion to intensive care unit in 5% (n = 13) of cases. Rare 
but severe complications included two cases of necrosis 
of the extremities (one case of two toes and another of 
three fingers of one hand) and one case of extended skin 
necrosis of the leg.
The average length of hospital stay was 11.2  days 
(1–106), with a mortality of 3.6% (n  =  9). In the latter 
cases, all patients had comorbidities (chronic alcoholism, 
heart failure and COPD) and were over 60-years old.
Discussion
Being MSF the most prevalent zoonosis in Portugal, 
we wanted to characterize the patients followed in our 
unit and evaluate if in the study period there were some 
changes in epidemiological data and clinical presentation.
Gender balance was similar to previous reports from 
our country (Sousa et al. 2003), although different from 
some studies in which a clear male predominance was 
found (Rovery and Raoult 2008).
Age distribution was the expected, as the author’s unit 
follows mainly adult cases.
The cyclical variation of the incidence throughout the 
study period was also found in other series, and is jus-
tified by the emergent or re-emergent characteristic of 
MSF (Rovery and Raoult 2008; Sousa et al. 2003).
The summer predominance that we found (78% of 
the cases occurring between July and September), was 
expected, and described in many articles (Rovery and 
Raoult 2008; Sousa et  al. 2003; Oliveira and Côrte-Real 
1999). The existence of cases diagnosed in colder months, 
as the one described with admission in December, testi-
fies that R. sanguineus preserves activity throughout the 
year (Rovery and Raoult 2008; Oliveira and Côrte-Real 
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1999), even more in Portugal, a country with warm tem-
peratures even in the colder months.
From the five most prevalent comorbidities, at least 
three are usually considered risk factors for severe MSF: 
diabetes, heart failure and chronic alcoholism (Sousa 
et  al. 2003; Oliveira and Côrte-Real 1999; Sousa et  al. 
2008; Sociedade Portuguesa de Pediatria 2005). Yet still, 
only 5% of patients (n =  13) needed intensive care unit 
admission.
The clear predominance of rural origin (78%, n = 194) 
of the affected patients found in this series contrasts with 
recent data that state that most of the cases are either of 
urban origin (Rovery and Raoult 2008) or that urban and 
rural populations are equally affected (Parola et al. 2013). 
This difference is easily justifiable by the geographic loca-
tion of our centre, and its vicinity with rural areas. The 
contact with dogs was only described in 34% (n = 85) of 
our patients, what calls into question the role of dogs as 
a reservoir of Rickettsia conorii. Although contact with 
other animals (small rodents, cats or farm animals) was 
found in 14 cases, the fact that Rhipicephalus sanguineus 
itself acts not only as vector, but also as reservoir (Rovery 
et al. 2008; Sousa et al. 2003; Duque et al. 2012; Sociedade 
Portuguesa de Pediatria 2005; Parola et al. 2013; Brouqui 
et al. 2004), may justify many of the cases without clear 
relation with dogs or other animals. Despite this fact, the 
true reservoir of Rickettsia conorii is still unknown (Rov-
ery et al. 2008). In our series, tick bite was noticed only 
by 10% (n =  26) of patients. Although inferior to other 
Portuguese case series (Sousa et  al. 2008), this result is 
easily understood by the difficulty to find a tick attached 
to the patient’s body, as it’s size is very small, particularly 
in the nymph stages. This stage of ticks has a peak activity 
in the warmer months (Rovery and Raoult 2008), exactly 
the ones in which more cases have been diagnosed.
The most frequent clinical manifestations found in our 
series were fever, rash, myoarthralgia, inoculation eschar 
and headache. These manifestations are similar with the 
classic descriptions of MSF. Despite this fact, the relative 
prevalence is different from other national series. Rita de 
Sousa et al. (2008), described a series with higher preva-
lence of inoculation eschar, rash, headache and gastro-
intestinal symptoms, what can be justified by different 
geographical origin of patients, but most of all, by the 
severity of cases presented in that series, with almost 30% 
admitted to an ICU (only 5% in our series).
The presence of an inoculation eschar, varies widely 
among different series. In ours it was found in 60% 
(n = 151), a result that is within values presented in other 
series (Louro et  al. 2006; Oliveira and Côrte-Real 1999; 
Sousa et al. 2008), which varied from 39 to 88%. In our 
series, in 84% (127/151) of the cases, the inoculation 
eschar was located on non-exposed areas of skin. It was 
multiple in only 2% of patients and located on the head in 
3%. Although weakly represented in our series, these two 
characteristics are described in association with different 
types of Rickettsiosis [multiple eschars with LAR (Fac-
cini-Martínez et al. 2014; Fournier et al. 2005; Sousa et al. 
2006; Pereira et  al. 2011)—and scalp eschar with “scalp 
eschar and neck lymphadenopathy following tick bite”—
SENLAT (Parola et al. 2013; Faccini-Martínez et al. 2014; 
Raoult et al. 1997; Sousa et al. 2013; Colomba et al. 2006; 
Angelakis et al. 2010)]. SENLAT is also know as TIBOLA 
(tick-borne lymphadenopathy) and DEBONEL (Derma-
centor-borne necrosis-erythema–lymphadenopathy), and 
can be caused by agents other than Rickettsia (Angelakis 
et al. 2010).
Although MSF, LAR and SENLAT are all included in 
the Rickettsiosis syndrome with a probability of inocula-
tion eschar (Faccini-Martínez et al. 2014), they constitute 
individual clinical entities.
Some clinical presentations previously considered 
atypical in MSF, such as multiple eschars, lymphangi-
tis, head eschars or cases in colder months, may also be 
associated to other Rickettsiosis. In the period of the pre-
sent series, some cases of less common Rickettsiosis have 
been described by our unit (Pereira et  al. 2011; Sousa 
et al. 2013).
The clinical case excluded from our series, of a patient 
presenting with two eschars and lymphangitis, was prob-
ably considered MSF because of fever, flu-like symptoms 
and the presence of inoculation eschars. Although not 
confirmed by laboratory tests, this case fits the descrip-
tion of LAR (Faccini-Martínez et al. 2014; Fournier et al. 
2005; Sousa et  al. 2006; Pereira et  al. 2011), and there-
fore was excluded from this case series. Also, the case of 
the patient presenting with an inoculation eschar on the 
head and an enlarged painful cervical lymph node, with-
out fever or rash, is similar to other cases of SENLAT 
described in the literature (Parola et  al. 2013; Faccini-
Martínez et al. 2014; Raoult et al. 1997; Sousa et al. 2013; 
Colomba et  al. 2006) and was also excluded. This diag-
nostic of MSF in this case was probably assumed because 
of the identification of a tick-bite and the inoculation 
eschar. On the other hand, the case diagnosed in Decem-
ber 2009, of a 33 year-old male veterinarian, although not 
in the predominant season for MSF, presented classic 
clinical manifestations, associated with serologic results. 
Using the scoring system described by Brouqui et  al. 
(2004), this case would have 37 points, confirming the 
diagnostic of MSF. This case stresses the importance of 
keeping MSF in mind even apart from summer months, 
particularly in warmer countries.
Clinical and epidemiologic aspects are crucial when 
diagnosing MSF, as laboratory results take too long to 
guide therapy, which must be started as early as possible. 
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When patients present characteristic clinical manifes-
tations, in the appropriate season of the year, diagnosis 
may be straightforward (Sousa et  al. 2003; Oliveira and 
Côrte-Real 1999). On the other hand, atypical cases must 
trigger the interest of clinicians to try to identify “non-
conorii rickettsiosis”, as they can suggest the emergence 
of Rikettsia species previously unknow in a region. In 
this process, PCR amplification from collected samples 
plays a central role, as it allows the identification of the 
species of Rickettsia involved (Rovery and Raoult 2008; 
Sousa et  al. 2008; Parola et  al. 2013; Faccini-Martínez 
et al. 2014). This identification would also enrich epide-
miological knowledge about species of Rickettsia present 
in a region (La Scola and Raoult 1997).
Complete blood count evaluation showed thrombo-
cytopenia in 60% (n  =  151) of patients, with no major 
change in leukocyte count. This result is characteristic of 
MSF (Oliveira and Côrte-Real 1999; Raoult et  al. 1986), 
and resolves with therapy. Biochemistry panel changes 
were also the usual in this pathology (Oliveira and Côrte-
Real 1999; Raoult et al. 1986), with elevation of liver func-
tion tests and C-reactive protein.
Acute phase serology (by immunofluorescence assay) 
was positive in 37% (78/212) of the cases in which it was 
done. From these, 55% (43/78) presented IgG  >  1/128. 
Seroconversion was documented in 85% (72/85). 
Paired serologies were obtained in 62% (131/212) of 
patients. In these, 20% (26/131) had a fourfold increase 
in titer between acute and convalescent phase. Gather-
ing the serologic results, diagnostic criteria (IgG  >  128 
in acute phase test, seroconversion or a fourfold titer 
raise between acute and convalescent test (Oliveira and 
Côrte-Real 1999; Sousa et al. 2008; Brouqui et al. 2004)—
excluding the ones that had already an acute test >128) 
were met in 63% (133/212) of the patients with serologic 
evaluation done. These results confirm that clinical eval-
uation is fundamental to guide diagnostic and treatment, 
even if later serologic confirmation is obtained.
The time interval between acute and convalescent 
phase serologies was usually 6–8  weeks, as this was 
the time when follow-up appointments were usually 
scheduled.
Subspecies identification, by culture or PCR amplifica-
tion tests was only successful in four cases, a number that 
does not allow for any comparison between the diseases 
caused by these two subspecies. In all this four cases, first 
serology was negative, being seroconversion confirmed.
The treatment of MSF is based in antibiotics with good 
intracellular activity, being doxycycline the most used in 
first-line therapy (Rovery and Raoult 2008; Parola et  al. 
2013). Alternatives are macrolides, particularly useful 
in pregnant women and chloramphenicol (Oliveira and 
Côrte-Real 1999; Parola et  al. 2013; Faccini-Martínez 
et  al. 2014; Cascio et  al. 2002; Colomba et  al. 2006). In 
our series antibiotic treatment included doxycycline in 
86% (n = 215) and chloramphenicol in 12% (n = 30), with 
a mean duration of 8 days. Azithromycin was only used 
once, in a 14 year-old boy, with resolution of disease.
Clinical improvement usually occurs within 48  h of 
treatment initiation and patients usually recover within 
10  days with no sequelae. Cases complicated by sepsis, 
shock and multiple organ failure (Rovery and Raoult 
2008; Oliveira and Côrte-Real 1999; Sousa et  al. 2008; 
Figueira-Coelho et  al. 2010; Duque et  al. 2012; Parola 
et  al. 2013; Amaro et  al. 2003; Colomba et  al. 2014) 
are rare, but may occur. They are usually seen in older 
patients, in people with comorbidities (diabetes mellitus, 
immunodepression, cardiac pathology, chronic alcohol-
ism and glucose-6-phosphate dehydrogenase deficiency) 
and in those who had inappropriate or delayed antibiotic 
treatment (Sousa et  al. 2003; Oliveira and Côrte-Real 
1999; Parola et al. 2013).
In our series, acute renal injury was the most frequent 
complication and was observed in 16% (n = 40) of cases, 
followed by respiratory failure in 15% (n = 37). Although 
meningoencephalitis is a rare complication, it was con-
sidered present in 7% (n  =  17) of patients and docu-
mented in one case (Duque et al. 2012). Multiple organ 
failure justified admission to intensive care unit in 5% 
(n = 13) of cases.
The average length of hospital stay was 11.2  days 
(1–106), with a mortality of 3.6% (n  =  9). The mortal-
ity is within Portuguese results presented in other series 
(Sousa et al. 2003; Oliveira and Côrte-Real 1999; Galvão 
et al. 2005; Sousa et al. 2008; Amaro et al. 2003). Yet still 
it decrease from 6% in the 1989–2001 period to 2% in the 
2002–2012 interval.
As expected, all the deceased had comorbidities 
(chronic alcoholism, heart failure and COPD) and were 
over 60 years old.
The patients that recovered from MSF had favourable 
outcome, with no sequelae.
Additional files
Additional file 1:  Figure S1. Age distribution.
Additional file 2:  Figure S2. Annual incidence.
Additional file 3:  Figure S3. Monthly distribution.
Additional file 4:  Table S1. Most frequent comorbidities.
Additional file 5:  Table S2. Clinical manifestations.
Additional file 6:  Table S3. Inoculation eschar location.
Additional file 7: Table S4. Serologic evaluation results (immunofluo‑
rescence assay).
Page 7 of 7Crespo et al. SpringerPlus  (2015) 4:272 
Authors’ contribution
All authors contributed in the conception and design of the study. PC, DS, NM 
had particular contribution in the acquisition, analysis and interpretation of 
data. PC drafted the manuscript and NM, JO, SC were responsible for the revi‑
sion of the manuscript. All authors read and approved the final manuscript.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 25 September 2014   Accepted: 13 May 2015
References
Amaro M, Bacellar F, França A (2003) Report of eight cases of fatal and severe 
mediterranean spotted fever in Portugal. Ann N Y Acad Sci 990:331–343
Angelakis E, Pulcini C, Waton J, Imbert P, Socolovschi C, Edouard S et al (2010) 
Scalp eschar and neck lymphadenopathy caused by Bartonella henselae 
after tick bite. Clin Infect Dis. doi:10.1086/650172
Bacellar F, Beati L, França A, Poças J, Regnery R, Filipe A (1999) Israeli spotted 
fever Rickettsia (Rickettsia conorii complex) associated with human dis‑
ease in Portugal. Emerg Infect Dis 5(6):835–836
Botelho‑Nevers E, Rovery C, Richet H, Raoult D (2011) Analysis of risk factors for 
malignant Mediterranean spotted fever indicates that fluoroquinolone 
treatment has a deleterious effect. J Antimicrob Chemoter 66:1821–1830
Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoërsdorff A, Blanco JR et al (2004) 
Guidelines for the diagnosis of tick‑borne bacterial diseases in Europe. 
Clin Microbiol Infect 10(12):1108–1132
Cascio A, Colomba C, Antinori S, Paterson D, Titone L (2002) Clarithromycin 
versus Azithromycin in the treatment of mediterranean spotted fever in 
children: a randomized controlled trial. Clin Infect Dis 34:154–158
Colomba C, Saporito L, Polara VF, Rubino R, Titone L (2006) Mediterranean 
spotted fever: clinical and laboratory characteristics of 415 Sicilian chil‑
dren. BMC Infect Dis. doi:10.1186/1471‑2334‑6‑60
Colomba C, Imburgia C, Trizzino M, Titone L (2014) First case of Mediterranean 
spotted fever‑associated rhabdomyolysis leading to fatal acute renal 
failure and encephalitis. Am J Infect Dis. doi:10.1016/j.ijid.2014.01.024
Duque V, Ventura C, Seixas D, Barai A, Mendonça N, Martins J et al (2012) Medi‑
terranean spotted fever and encephalitis: a case report and review of the 
literature. J Infect Chemother 18(1):105–108
Faccini‑Martínez AA, García‑Álvarez L, Hidalgo M, Oteo JA (2014) Syndromic 
classification of rickettsioses: an approach for clinical practice. Int J Infect 
Dis. doi:10.1016/j.ijid.2014.05.025
Figueira‑Coelho J, Martins T, Machado J, Maltez F (2010) Atypical case of Medi‑
terranean spotted fever. Braz J Infect Dis. 14(3):213–216
Fournier PE, Gouriet F, Brouqui P, Lucht F, Raoult D (2005) Lymphangitis‑
associated rickettsiosis, a new rickettsiosis caused by Rickettsia sibirica 
mongolotimonae: seven new cases and review of the literature. Clin Infect 
Dis 40:1435–1444
Galvão MA, Silva LJ, Nascimento EM, Calic SB, Sousa R, Bacellar F (2005) Riquet‑
sioses no Brasil e Portugal: ocorrência, distribuição e diagnóstico. Rev 
Saude Publica 39(5):850–856
Garcia‑Alvarez L, Palomar AM, Oteo JA (2013) Prevention and prophylaxis of 
tick bites and tick‑borne related diseases. Am J Infect Dis. doi:10.3844/
ajidsp.2013.104.116
La Scola B, Raoult D (1997) Laboratory diagnosis of rickettsioses: current 
approaches to diagnosis of old and new rickettsial diseases. J Clin Micro‑
biol 35(11):2715–2727
Louro E, Campos A, Leitão J, Carvalho A, Santos RM, Reis C et al (2006) Febre 
escaro‑nodular: uma zoonose benigna? Revista da Soc Port Med Inter 
13(1):14–18
Oliveira J, Côrte‑Real R (1999) Rickettsioses em Portugal. Acta Med Port 
12:313–321
Parola P, Paddock CD, Socolovschi C, Labruna MB, Mediannikov O, Kernif T et al 
(2013) Update on tick‑borne rickettsioses around the world: a geographic 
approach. Clin Microbiol Rev 26(4):657–702
Pereira BI, Seixas D, Malcata L, Serra JE, Oliveira J, da Cunha Saraiva et al (2011) 
Infecção por Rickettsia sibirica mongolitimonae em Portugal—caso clínico. 
Rev Port Doenças Infec 7(1):35–39
Raoult D, Weiller P, Chagnon A, Chaudet H, Gallais H, Casanova P (1986) Medi‑
terranean spotted fever: clinical, laboratory and epidemiological features 
of 199 cases. Am J Trop Med Hyg 35(4):845–850
Raoult D, Berbis Ph, Roux V, Xu W, Maurin M (1997) A new tick‑transmitted 
disease due to Rickettsia slovaca. Lancet 350:112–113
Rovery C, Raoult D (2008) Mediterranean spotted fever. Infect Dis Clin North 
Am 22:515–530
Rovery C, Brouqui P, Raoult D (2008) Questions on mediterranean spotted 
fever a century after its discovery. Emerg Infect Dis 14(9):1360–1367
Santos FM (2014) “PORDATA—Base de dados Portugal contemporâneo.” http://
www.pordata.pt/Portugal/Doencas+de+declaracao+obrigatoria+casos
+notificados‑773. Accessed 24 Jul 2014
Sociedade Portuguesa de Pediatria (2005) Consensos em Infecciologia 
Pediátrica—Febre escaro‑nodular. Acta Pediatr Port 36(5):257–263
Sousa R, Nóbrega SD, Bacellar F, Torgal J (2003) Sobre a realidade da febre 
escaro‑nodular em Portugal. Acta Med Port 16:429–436
Sousa R, Barata C, Vitorino L, Santos‑Silva M, Carrapato C, Torgal J et al (2006) 
Rickettsia sibirica isolation from a patient and detection in ticks Portugal. 
Emerg Infect Dis 12(7):1103–1108
Sousa R, França A, Nóbrega SD, Belo A, Amaro M, Abreu T et al (2008) Host‑ 
and microbe‑related risk factors for and pathophysiology of fatal Rickett-
sia conorii infection in Portuguese patients. J Infect Dis 198:576–585
Sousa R, Pereira BI, Nazareth C, Cabral S, Ventura C, Crespo P et al (2013) 
Rickettsia slovaca infection in Humans Portugal. Emerg Infect Dis 
19(10):1627–1629
Walker DH, Raoult D (2010) Rickettsia rickettsii and other spotted fever group 
Rickettsiae (Rocky mountain spotted fever and other spotted fevers). In: 
Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s 
principles and practice of infectious diseases, vol 2, 7th edn. Churchill 
Livingstone Elsevier, Philadelphia, pp 2499–2507
